To evaluate the prognostic performance of galectin-3, we compared a baseline clinical model [model 1: age, sex, LVEF, SBP, body mass index (BMI), diabetes mellitus (DM) and hsCRP] with models incorporating BNP, galectin-3 or both. The gene discussed is LGALS3; the disease is diabetes mellitus.